Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Dyer, Mitchell R ^a   Chen, Qiwei ^a   Haldeman, Shannon ^a   Yazdani, Hamza ^a   Hoffman, Rosemary ^a   Loughran, Patricia ^a,b   Tsung, Allan ^a   Zuckerbraun, Brian S ^a   Simmons, Richard L ^a   Neal, Matthew D ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, MOUSE;

ANIMAL; C57BL MOUSE; CELL CULTURE; EXTRACELLULAR TRAP; MALE; METABOLISM; MOUSE; NEUTROPHIL; PATHOLOGY; THROMBOCYTE; VEIN THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CELLS, CULTURED; DNA; EXTRACELLULAR TRAPS; HMGB1 PROTEIN; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; VENOUS THROMBOSIS;

EID: 85041584450     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-20479-x     Document Type: Article

References (30)

1. Heit, J. A. Epidemiology of venous thromboembolism. Nat. Rev. Cardiol. 12, 464-74 (2015).
2. Kearon, C. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149, 315-352 (2016).
3. Vogel, S. et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest 125(12), 4638-54 (2015).
4. Stark, K. et al. Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice. Blood 128, 2435-2450 (2016).
5. Engelmann, B. &Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13, 34-45 (2012).
6. Mackman, N. New insights into the mechanisms of venous thrombosis. J. Clin. Invest. 122, 2331-6 (2012).
7. Saghazadeh, A. &Rezaei, N. Inflammation as a cause of venous thromboembolism. Crit. Rev. Oncol. Hematol. 99, 272-285 (2016).
8. Ito, T. et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J. Thromb. Haemost. 5, 109-116 (2007).
9. Yang, H., Wang, H., Chavan, S. S. &Andersson, U. High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule. Mol. Med. 21 Suppl, 1 S6-S12 (2015).
10. Tsung, A., Tohme, S. &Billiar, T. R. High-mobility group box-1 in sterile inflammation. J. Intern. Med. 276, 425-443 (2014).
11. Carestia, A., Kaufman, T. &Schattner, M. Platelets: New Bricks in the Building of Neutrophil Extracellular Traps. Front. Immunol. 7, 271 (2016).
12. Brill, A. et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 10, 136-44 (2012).
13. von Brühl, M.-L. et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819-35 (2012).
14. Martinod, K. et al. Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis. J. Thromb. Haemost. n/a-n/a 14, 551-8, https://doi.org/10.1111/jth.13239 (2015).
15. Heestermans, M. et al. Role of platelets, neutrophils, and factor XII in spontaneous venous thrombosis in mice. Blood 127, 2630-7, https://doi.org/10.1182/blood-2015-10-672766 (2016).
16. Martinod, K. et al. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice. Proc. Natl. Acad. Sci. USA 110, 8674-9 (2013).
17. Etulain, J. et al. P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126, 242-246 (2015).
18. Henke, P. K. et al. Deep Vein Thrombosis is Modulated by Monocyte CXCR2-Mediated Activity in a Mouse Model. Arterioscler. Thromb. Vasc. Biol. 24, 1130-7 (2004).
19. Calcagno, C., Lobatto, M. E., Robson, P. M. &Millon, A. HHS Public Access. 28, 1304-1314 (2016).
20. Ahrens, I. et al. HMGB1 binds to activated platelets via platelet-expressed receptor for advanced glycation end products (RAGE) and is highly expressed in platelet rich coronary artery thrombi. Thromb. Haemost. 14, 994-1003 (2015).
21. Cohen, M. J. et al. Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion. Crit. Care 13, R174 (2009).
22. Yang, L. et al. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat. Commun. 5, 4436 (2014).
23. Kang, R. et al. HMGB1 in health and disease. Mol. Aspects Med. 40, 1-116 (2014).
24. Martinod, K. &Wagner, D. D. Thrombosis: tangled up in NETs. Blood 123, 2768-76 (2014).
25. El-Sayed, O. M. et al. Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice. J. Vasc. Surg. 9, 1-10 (2015).
26. Culmer, D. et al. Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model. Thrombosis Research 131, 42-48 (2013).
27. Myers, D. et al. Decreased venous thrombosis with an oral inhibitor of P selectin. J Vasc Surg 42, 329-336 (2005).
28. Gould, T. J., Lysov, Z. &Liaw, P. C. Extracellular DNA and histones: Double-edged swords in immunothrombosis. J. Thromb. Haemost. 13, S82-S91 (2015).
29. Noubouossie, D. F. et al. In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. Blood 129, 1021-1030 (2016).
30. Jiménez-Alcázar, M. et al. Circulating Extracellular DNA: Cause or Consequence of Thrombosis? https://doi.org/10.1055/s-0036-1597284.